mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary
暂无分享,去创建一个
J. Testa | M. Ohmichi | M. Hayashi | S. Mabuchi | K. Sawada | R. Schilder | Andres J Klein-Szanto | D. Altomare | M. Tsujimoto | K. Morishige | M. Yamoto | T. Kimura | C. Kawase | Kenjiro Sawada | Ken‐ichirou Morishige